SCHEMBL27108161

SCHEMBL27108161

CC(C)c1cccc(-c2cnn[nH]2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXRA P19793 2/20 0.41
▸ RXRB P28702 1/20 0.41
▸ RXRG P48443 1/20 0.41
▸ METAP2 P50579 1/20 0.37
▸ PTPN5 P54829 2/20 0.36
▸ CTSS P25774 1/20 0.35
▸ CTSK P43235 1/20 0.35
▸ NR4A2 P43354 1/20 0.35
▸ HDAC4 P56524 2/20 0.35
▸ HDAC8 Q9BY41 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ MDM4 O15151 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ CA1 P00915 1/20 0.35
▸ CA2 P00918 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ TYR P14679 1/20 0.35
▸ HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23329062 0.79 RAB9A (0.44) KDM4ETP53MAPTTYRHPGD
SCHEMBL24665780 0.75 NOTUM (0.57) RXRARXRBRXRGNOTUM
SCHEMBL28586915 0.75 HDAC4 (0.36) RXRARXRBRXRGMETAP2HDAC4
SCHEMBL28584793 0.75 HDAC4 (0.36) RXRARXRBRXRGMETAP2HDAC4
SCHEMBL28600791 0.75 HDAC4 (0.36) RXRARXRBRXRGMETAP2PTPN5
SCHEMBL28578099 0.75 HDAC4 (0.36) RXRARXRBRXRGMETAP2HDAC4
SCHEMBL30171029 0.74 IDO1 (0.54) ALDH1A1TP53MAPTHPGDALOX15
SCHEMBL1822901 0.74 NOTUM (0.33) NOTUM
SCHEMBL5020146 0.74 HSD17B1 (0.48) METAP2ALDH1A1CA2CYP3A4CA5A
SCHEMBL8780977 0.74 NOTUM (0.33) NOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024044757-A1 AMINOPYRIMIDINE AND AMINOTRIAZINE DERIVATIVES AS MYC PROTEIN MODULATORS Sanford Burnham Prebys Medical Discovery Institute (US) 2024-02-29 — — WO disclosed
Send feedback